On Nov. 26, 2014, Medtronic announced that it had received clearance from the US Federal Trade Commission to acquire Covidien. The agreement includes a commitment to divest certain assets related to Covidien s drug-coated balloon catheter product. Earlier in the month, Spectranetics announOriginal Article
You may also like
New alloys for manufacturing freeze-dryers
Navigating the Complexities of Emerging Therapy...
INTERPHEX 2025: Preventing Spills in the Manufacturing...
Agentic AI Growth Predicted, but More Than Half of...
Microsoft and SkyCell Collaborate on Pharma Supply...
Siemens Acquires Dotmatics, Extending AI Software...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.